Monday, July 12, 2021 – DIA 350.03 +.37%, QQQ 362.42 +.39%, SPY 437.08 +.36%
No high-impact data was released. The major indexes hit new highs, but small caps underperformed. The 3 and 10 year Treasury note auctions were lackluster. The 10-year Note Index (TNX) 13.63 +.07 moved higher as markets prepared for the CPI print Tuesday morning. Financials (XLF) 37.07 +.98% outperformed ahead of the release of earnings by Goldman Sachs (GS) 380.50 +2.35% and JPMorgan (JPM) 158.00 +1.43%. Basic materials provider Albermarle (ALB) 187.49 + 6.83% led the S&P 500 as investors appeared to take interest in the company as a provider of lithium for EV battery production. In M&A activity, State Auto Financial (STFC) 50.22 +191% announced it agreed to be acquired by its majority stockholder Liberty Mutual. In biotechnology, Celldex (CLDX) 40.67 +25.49% released positive data for a phase 1b trial experimental treatment CDX-0159 for hives. Virgin Galactic (SPCE) 40.69 -17.30 continuing its recent pattern of high volatility moved lower on a “sell the news” response to a successful trip into space by its founder Richard Branson.

Tuesday, July 13, 2021 – DIA 349.00 -.29%, QQQ 362.42 unch, SPY 435.59 -.34%
The Consumer Price Index (CPI) was released at the highest level since 2008 coming in at an increase of 5.4% (YoY) far higher than the 4.9% expected. Big earnings released by JPMorgan (JPM) 155.65 -1.49% Goldman Sachs (GS) 375.98 -1.19% were greeted with a lackluster consolidation of the shares. JD.com (JD) 76.52 + 4.58%, NetEase (NTES) 112.17 +2.97%, Baidu (BIDU) 184.59 +2.33% led the NASDAQ 100 as China’s top regulator approved Tencent Holdings (TCEHY) 70.96 +3.76% plan to privatize search-engine Sogou. In M&A activity Howard Bancorp (HBMD) 19.79 +26.70% agreed to merge with F.N.B. Corporation (FNB) 11.74 -3.77%. In healthcare, IV device and MRI machine maker IRadimed (IRMD) 37.21 +11.27% continued a second day of upside volatility after a breakout. Celldex (CLDX) 44.60 +9.66% continued its advance from Monday’s news. On the downside Conagra Brands (CAG) 33.98 -5.43% beat on earnings and revenue but said input costs would cut into earnings going forward. Norwegian Cruise Lines (NCLH) 26.09 -4.36% and Carnival (CCL) 22.85 -4.23%  were weak on continued news of regulatory requirements by the state of Florida forbidding cruise lines from requiring proof of vaccination for COVID-19 and other news related to the pandemic.

Wednesday, July 14, 2021 – DIA 349.41 +.12%, QQQ 363.07 +.18%, SPY 436.24 +.15%
The Producer Price Index (PPI) was released showing an increase of 5.6% (YoY) vs. far higher than the expectation of 5.1%. Fed chair Powell gave testimony to Congress repeating his contention that inflation will be transitory. Treasury bonds rallied and the 10-Year Note index (TNX) 13.56 -.59 dropped markedly in sympathy. Apple Inc. (AAPL) 149.35 149.15 +2.41% continued to hit new highs while leading the DJIA for the day. Wells Fargo (WFC) 44.95 +3.98% led the S&P 500 after reporting earnings with the best revenue since before the pandemic. (XLE) 50.10 –1.40% continued to underperform with Occidental (OXY) 27.83 -7.48%, Diamondback (FANG) 84.58 -6.06%, Devon (DVN) 27.30 -5.76%, APA Corporation (APA) 19.04 -5.6% the worst performers in the S&P 500. Kura Sushi (KRUS) 47.51 +23.15% was the upside surprise on the day after releasing earnings and receiving an upgrade by Craige-Hallum from a Hold to a Buy and price target raised from $40 to $48 per share in line with the day's performance. The company stated that diners had returned and all restaurants were operating at full capacity. CorePoint Lodging (CPLG) 13.45 +21.83% gave a quarter business update and gave a notice that it was exploring strategic options for its portfolio of hotels. On the downside,  GLaukos (GKOS) Corporation 57.82 -21.41% received downgrades by William Blair and Oppenheimer after reporting that it had received a disappointing proposed 2022 physician fee schedule by the Centers for Medicare & Medicaid Services (CMS).

Thursday, July 14, 2021 – DIA 349.94 +.15%, QQQ 360.52 -.70%, SPY 434.75 -.34%
Initial jobless claims came in as expected at 360K. The Philadelphia Fed Manufacturing index came in much weaker than expected at 21.9 v. 28. The 10-Year Note Index (TNX) 12.97 -.59 declined hard. Utilities outperformed (XLU) 65.61 +1.13% outperformed. Energy (XLE) 50.10 -1.40 continued as the laggard group. Baidu (BIDU) 185.52 +2.31% and JD.com (JD) 76.86 +1.87% led the NASDAQ 100. Biogen (BIIB) 328.16 -6.79% declined on news that the FDA has requested the internal inspector general conduct a review of how the FDA approved the Biogen drug Aduhelm. Data storage company Western Digital (WDC) 66.91 -4.43% declined and was the second-worst performer in the S&P500. The shares recently tested the overhead 20 and 50-day moving averages and now are testing the bottom of a trend channel dating back to late March 2021. Kura Sushi (KRUS) 51.39 +8.17% continued its rally from the previous day’s earnings release.

Friday, July 15, 2021 – DIA 346.74 -.86%, QQQ 357.60 -.81%, SPY 431.41 -.77%
Retail sales +.6% (MoM) came in much stronger than the negative -.4% anticipated. Ex-Autos was far stronger at +1.3% v. +.4% expected. The University of Michigan Preliminary Consumer Confidence Survey fell unexpectedly to the lowest level since February on inflation fears, coming in at a reading of 80.8 vs. an 86.5% expectation. The markets traded defensively throughout the day, with Utilities (XLU) 66.27 +1.01% and Healthcare (XLV) 128.62 +.27% performing best. Energy (XLE) 48.68 -2.83% continued striking underperformance with pronounced continued weakness in both Occidental (OXY) 25.94 -4.74% and Diamondback (FANG) 78.36 -4.14%. The city of Los Angeles announced the re-imposition of indoor mask mandates. Continuing COVID-19 headlines throughout the day affected travel & entertainment shares. Cruise lines continued their weakness with Norwegian (NCLH) 23.14 -5.35% and Carnival (CCL) 20.92 -4.69% down. In biotech, FibroGen (FGEN) 14.35 -42.24% was nearly cut in half as an FDA advisory panel recommended against approval of roxadustat as a treatment for anemia for chronic kidney disease. The shares are well off their highs of 57.21 on February 12.

DISCLAIMER
The content of this message and its attachments are intended only for the informational and educational use for the intended recipient and may contain confidential and privileged information. If you are not the intended recipient, any dissemination, distribution, or copying of this message or its attachments is prohibited. If you received this message in error, please notify the sender by replying to this email immediately and delete this message and its attachments from your computer. This content does not constitute an offer to sell or a solicitation to buy any security or instrument which may be referenced upon the site, or an offer to provide advisory or other services by the writer or company employing the writer in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. All communications sent to or from TradeZero, Inc. are subject to archive and review by TradeZero, Inc. and by regulatory and law enforcement authorities. We explicitly disclaim all liability for any action taken based on any information contained in this writing.